A Q&A on the IRA
The Inflation Reduction Act has the potential to lower prescription drug costs for millions of Americans and raise them for millions more. Who stands to gain or lose?
Healthcare Costs
The Adderall Shortage Is Real – Here’s How RxSS Helps Members
We know many members are scrambling to find pharmacies with the common ADHD medication in stock. With this and other drug shortages, RxSS can be an invaluable resource.
The Adderall Shortage Is Real – Here’s How RxSS Helps Members Read More »
Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Humira Biosimilars and other Biologic Alternatives Read More »
Prescription Drug Options – Pharmacist Curated, Doctor Approved
Members shouldn’t confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. RxSS informs those discussions, and makes it easy to make a change.
Prescription Drug Options – Pharmacist Curated, Doctor Approved Read More »
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now
Free PBM tools can help members get more from their pharmacy benefits, maybe even save on certain prescriptions. What more can you ask for? Quite a bit, actually.
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now Read More »
Specialty Copay Programs – Accumulate, Maximize or Avoid?
Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, but it’s crucial to understand how they fit into your benefit and where they improve or hinder your plan.
Specialty Copay Programs – Accumulate, Maximize or Avoid? Read More »
Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Let’s Talk About Mental Health Read More »
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor Read More »
Dexilant Generic Joins the PPI Party, But Plenty of Alternatives Already Have
A widely prescribed acid reflux medication now has an authorized generic available. Good news, but five low-cost proton-pump inhibitor (PPIs) generics often work just as well.
Dexilant Generic Joins the PPI Party, But Plenty of Alternatives Already Have Read More »
Whatever the Numbers Say, Guess Who Keeps Paying More for Rx?
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
Whatever the Numbers Say, Guess Who Keeps Paying More for Rx? Read More »
